Watch Ticker

Immatics N.V. Warrants

Go to Immatics N.V. Warrants Website

$0.00

(%)

Live

Previous Close

$0.0006

Day Range

$ - $

Previous Day Range

$ - $

Market Cap

Day Vol.

Previous Day Vol.

Currency

Primary Exchange

Nasdaq

...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Delveinsight - TCR Therapy Clinical Trial Pipeline Accelerates as 80+ Pharma Companies Rigorously Developing Drugs for the Market Entry | DelveInsight

The T-cell receptor (TCR) therapy pipeline is rapidly expanding, with over 80 pharmaceutical companies actively developing more than 100 TCR therapies for various cancers, including solid tumors. Several promising pipeline candidates are in different stages of clinical trials, showcasing the potential of TCR therapy to revolutionize cancer treatment.

Related tickers: IMCR, TCRX, IMTX, IMTXW.

Read Full Article

N/A - Immatics Announces Multiple Presentations at the 39th Annual Meeting of the Society for Immunotherapy of Cancer (SITC) on TCR-T Therapy Candidates Targeting PRAME

Immatics announced positive clinical data for its TCR-T therapy candidates targeting PRAME, a protein frequently expressed in solid cancers. The data showed deep and durable responses in heavily pretreated patients, supporting the advancement of these therapies into late-stage development.

Related tickers: IMTX, IMTXW.

Read Full Article

Trending Tickers

Please sign in to view